<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT2016110230657N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2016-11-18</date_registration>
      <primary_sponsor>Mohaghegh Ardabili University</primary_sponsor>
      <public_title>The effect of specific training on ground reaction forces charactrestics during landing in individuals with genu valgum</public_title>
      <acronym></acronym>
      <scientific_title>The effect of specific training on ground reaction forces charactrestics during landing and gait in individuals with genu valgum</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2016-11-08</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>26</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/24289</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Genu valgum.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Elastic tubing (Thera-Band, Akron, Ohio, US) ranging from very low to very high resistance (yellow, red, green, blue, black and silver) will be used. The Intervention group will be performed stretch training protocol (first two weeks) for the hip adductor, biceps femoris and tensor fascia latae  muscles consisted of static stretching performed in four sets of 30s for each movement. After stretch training protocols, the experimental group wil be performed resistance thera-band exercises at three times per week for fourteen weeks (i.e., 42 strength training sessions). The participants will be familiarized with the training techniques prior to training. Each exercise session will be consisted of a general warm-up of 10 minutes, followed by a resistance training session (35- 40 minutes) and was completed by a cool-down routine. Exercises were preceded by warm-up sets, while all thera-band training was closely will be supervised and the participants will be received consistent verbal instructions. Following an adaptation phase of four weeks using low external resistance (yellow Thera-Band®, 1 set of 14 repetitions per exercise with a higher resistance only if the subject was obviously unchallenged) exercise intensity was progressively increased by adapting the resistance of the elastic band (based on the Thera-Band® force-elongation table) from yellow to red and further to black. In addition, the exercise volume will be extended by increasing the number of sets from one to two. Rate of progression will be based on individual improvements (band colour will be changed if participant would have been able to perform two more repetitions in the second set) . Intervention 2: Control group: The control group did not perform any strengthening or stretching exercises and their participants were re-evaluated after 16 weeks.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan></results_IPD_plan>
      <results_IPD_description></results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mohsen Barghamadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Department of Physical Education and Sport Sciences, Mohaghegh Ardabili University, Ardabil city, Ardabil province, Iran.</address>
        <city>Ardabil</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip></zip>
        <telephone>+98 45 3351 2081</telephone>
        <email>AmirAlijafarnezhad@gmail.comsalehbarghamadi@yahoo.com</email>
        <affiliation>Mohaghegh Ardabili University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>AmirAli Jafarnezhadgero</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Department of Physical Education and Sport Sciences, Mohaghegh Ardabili University, Ardabil city, Ardabil province, Iran.</address>
        <city>Ardabil</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip></zip>
        <telephone>+98 45 3351 0903</telephone>
        <email>AmirAlijafarnezhad@gmail.comA.jafarnezhad90@basu.ac.ir</email>
        <affiliation>Mohaghegh Ardabili University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Inclusion criteria: Age range between 60-70 years; Q angle greater than 18 degree; Medial malleolus distance greater than 6 cm.&#13;
Exclusion criteria: History of lower limbs injury; History of lower limbs surgery; Body Mass Index greater than 30.</inclusion_criteria>
      <agemin>60 years</agemin>
      <agemax>70 years</agemax>
      <gender>Male</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>Q74.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Genu valgum</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Elastic tubing (Thera-Band, Akron, Ohio, US) ranging from very low to very high resistance (yellow, red, green, blue, black and silver) will be used. The Intervention group will be performed stretch training protocol (first two weeks) for the hip adductor, biceps femoris and tensor fascia latae  muscles consisted of static stretching performed in four sets of 30s for each movement. After stretch training protocols, the experimental group wil be performed resistance thera-band exercises at three times per week for fourteen weeks (i.e., 42 strength training sessions). The participants will be familiarized with the training techniques prior to training. Each exercise session will be consisted of a general warm-up of 10 minutes, followed by a resistance training session (35- 40 minutes) and was completed by a cool-down routine. Exercises were preceded by warm-up sets, while all thera-band training was closely will be supervised and the participants will be received consistent verbal instructions. Following an adaptation phase of four weeks using low external resistance (yellow Thera-Band®, 1 set of 14 repetitions per exercise with a higher resistance only if the subject was obviously unchallenged) exercise intensity was progressively increased by adapting the resistance of the elastic band (based on the Thera-Band® force-elongation table) from yellow to red and further to black. In addition, the exercise volume will be extended by increasing the number of sets from one to two. Rate of progression will be based on individual improvements (band colour will be changed if participant would have been able to perform two more repetitions in the second set) .</i_keyword>
      <i_keyword>Control group: The control group did not perform any strengthening or stretching exercises and their participants were re-evaluated after 16 weeks.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Ground reaction forces. Timepoint: before and after 16 weeks. Method of measurement: Forceplatform.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Q angle. Timepoint: before and after 16 weeks. Method of measurement: Goniameter.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Mohaghegh Ardabili University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2016-11-03</approval_date>
        <contact_name>Ardabil university of medical sciences</contact_name>
        <contact_address>Ardabil province- Ardabil city-Ardabil university of medical sciences Ardabil  Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
